Remove 2011 Remove Innovation Remove Management Remove Pharmaceuticals
article thumbnail

Pfizer’s Straight Talk on Culture

Michael Lee Stallard

Pfizer, the multinational pharmaceutical giant, has become increasingly intentional about shaping its culture. You can see evidence of Pfizer’s commitment in Ian Read’s letter to stakeholders the year after he became CEO: In 2011, we thoroughly explored what our culture is and how it needs to evolve. Pfizer people care.

Ethics 150
article thumbnail

3 Ways to Confront Economic Adversity in 2011

Coaching Tip

In a capitalist democracy, government should not be involved with what we in the private sector do, which is managing time to manage money. All it takes is the desire to be innovative and creative in tackling a problem. Entrepreneurship. You needn’t work for yourself – or even be working at all – to be an entrepreneur.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Performance Measurement

Strategy Driven

While you can find numerous books focused on the topic of corporate finance, few offer the type of information managers need to help them make important decisions day in and day out. Examines ways to maintain and grow value through mergers, acquisitions, and portfolio management.

ROIC 62
article thumbnail

Why The Best Hospitals Are Managed by Doctors

Harvard Business Review

A study published in 2011 examined CEOs in the top-100 best hospitals in USNWR in three key medical specialties: cancer, digestive disorders, and cardiovascular care. A simple question was asked: are hospitals ranked more highly when they are led by medically trained doctors or non-MD professional managers?

article thumbnail

Private Equity Can Make Firms More Innovative

Harvard Business Review

And a recent working paper out of the Dusseldorf Institute for Competition Economics ( DICE ), a think tank of sorts, focuses on the latter by exploring whether leveraged buyouts (LBOs) make firms more innovative. PE investors don’t typically invest in firms known for innovation. ” There were other limitations.

LBO 8
article thumbnail

India Remakes Global Innovation

Harvard Business Review

We recently visited the brand-new R&D lab of Dr Reddy's , one of India's leading pharmaceutical firms. In 2008, Dr Reddy's acquired Chirotech, Dow Chemical's R&D unit, for $32 million, and in April 2011 relocated it to a new 33,000 sq. Besides Dr Reddy's, several leading Indian firms are pioneering polycentric innovation: Tata Motors.

article thumbnail

Lipitor and iPhone 4s: Setting the Stage for Industry Disruption

Harvard Business Review

The two biggest product stories of 2011 were arguably Lipitor and the iPhone 4S. The Lipitor story seems to be about a managed end: the highly anticipated demise (due to the expiration of its patent last Nov. Apple use life-cycle management to explore a new way to drive the business and business model forward. Both Pfizer and.